Haemonetics Corp. (HAE)
102.92
+0.97
(+0.95%)
USD |
NYSE |
Sep 02, 16:00
103.13
+0.21
(+0.20%)
Pre-Market: 20:00
Haemonetics Cash from Investing (Quarterly) : -22.23M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.23M |
| March 31, 2026 | -86.61M |
| December 31, 2025 | -29.47M |
| September 30, 2025 | -30.47M |
| June 30, 2025 | -33.00M |
| March 31, 2025 | 18.04M |
| December 31, 2024 | -17.37M |
| September 30, 2024 | -23.37M |
| June 30, 2024 | -139.20M |
| March 31, 2024 | -13.06M |
| December 31, 2023 | -268.94M |
| September 30, 2023 | -25.14M |
| June 30, 2023 | -15.26M |
| March 31, 2023 | -18.01M |
| December 31, 2022 | -36.50M |
| September 30, 2022 | -31.07M |
| June 30, 2022 | -58.21M |
| March 31, 2022 | -34.51M |
| December 31, 2021 | -15.46M |
| September 30, 2021 | -20.52M |
| June 30, 2021 | -15.85M |
| March 31, 2021 | -429.10M |
| December 31, 2020 | -9.581M |
| September 30, 2020 | 37.14M |
| June 30, 2020 | -23.90M |
| Date | Value |
|---|---|
| March 31, 2020 | -45.14M |
| December 31, 2019 | -19.87M |
| September 30, 2019 | 5.964M |
| June 30, 2019 | 1.861M |
| March 31, 2019 | -13.22M |
| December 31, 2018 | -27.58M |
| September 30, 2018 | -48.08M |
| June 30, 2018 | -27.26M |
| March 31, 2018 | -17.97M |
| December 31, 2017 | -26.29M |
| September 30, 2017 | -15.04M |
| June 30, 2017 | -3.74M |
| March 31, 2017 | -14.57M |
| December 31, 2016 | -17.32M |
| September 30, 2016 | -19.04M |
| June 30, 2016 | -22.39M |
| March 31, 2016 | -28.29M |
| December 31, 2015 | -23.64M |
| September 30, 2015 | -25.71M |
| June 30, 2015 | -27.13M |
| March 31, 2015 | -21.62M |
| December 31, 2014 | -29.65M |
| September 30, 2014 | -33.47M |
| June 30, 2014 | -37.02M |
| March 31, 2014 | -30.81M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Globus Medical, Inc. | -129.05M |
| Abbott Laboratories | -673.00M |
| AngioDynamics, Inc. | -1.27M |
| Alphatec Holdings, Inc. | -22.72M |
| AtriCure, Inc. | -3.766M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 52.32M |
| Cash from Financing (Quarterly) | -51.53M |
| Free Cash Flow | 291.22M |
| Free Cash Flow Per Share (Quarterly) | 0.9718 |
| Free Cash Flow to Equity (Quarterly) | 144.98M |
| Free Cash Flow to Firm (Quarterly) | 51.47M |
| Free Cash Flow Yield | 6.07% |